1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Chondrosarcoma Global Clinical Trials Review, H1, 2014

Chondrosarcoma Global Clinical Trials Review, H1, 2014

  • March 2014
  • -
  • Global Data
  • -
  • 105 pages

Chondrosarcoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Chondrosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chondrosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chondrosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chondrosarcoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chondrosarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Chondrosarcoma 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Chondrosarcoma Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Chondrosarcoma 28
Jun 18, 2012: Infinity Pharma Stops Phase II Trials Of Saridegib In Chondrosarcoma And Myelofibrosis 28
Oct 17, 2011: Infinity Provides Update On Phase II Trial Of IPI-926 In Chondrosarcoma 28
Jun 13, 2011: Arizona Oncology Enrolls Patients In Phase II Clinical Trial Of IPI-926 In Patients With Chondrosarcoma 29
Apr 03, 2011: Infinity Reports New Preclinical Data For IPI-926 At AACR Supporting Development In Chondrosarcoma 29
Mar 23, 2011: Infinity To Present New Preclinical Data On IPI-926 At Upcoming AACR Meeting 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Infinity Pharmaceuticals, Inc. 31
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 31
F. Hoffmann-La Roche Ltd. 32
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 32
Agios Pharmaceuticals, Inc. 33
Clinical Trial Overview of Agios Pharmaceuticals, Inc. 33
AEterna Zentaris Inc. 34
Clinical Trial Overview of AEterna Zentaris Inc. 34
ACORN Research, LLC 35
Clinical Trial Overview of ACORN Research, LLC 35
Clinical Trial Overview of Top Institutes / Government 36
National Cancer Institute 36
Clinical Trial Overview of National Cancer Institute 36
Southwest Oncology Group 37
Clinical Trial Overview of Southwest Oncology Group 37
The University of Texas M. D. Anderson Cancer Center 38
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 38
Massachusetts General Hospital 39
Clinical Trial Overview of Massachusetts General Hospital 39
Memorial Sloan Kettering Cancer Center 40
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 40
Radiation Therapy Oncology Group 41
Clinical Trial Overview of Radiation Therapy Oncology Group 41
Roswell Park Cancer Institute 42
Clinical Trial Overview of Roswell Park Cancer Institute 42
University of Washington 43
Clinical Trial Overview of University of Washington 43
Stanford University 44
Clinical Trial Overview of Stanford University 44
Five Key Clinical Profiles 45
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 103
Secondary Research 103
About GlobalData 104
Contact Us 104
Disclaimer 104
Source 105

List of Tables
Chondrosarcoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Chondrosarcoma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Chondrosarcoma Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014* 31
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 32
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Agios Pharmaceuticals, Inc., 2014* 33
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2014* 34
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ACORN Research, LLC, 2014* 35
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 36
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 37
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 38
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 39
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 40
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 41
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014* 42
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 43
Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 44

List of Figures
Chondrosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.